(Q46644252)

23 December 2017

title

Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial (English)

1 reference

23 December 2017

0 references

1 reference

1 reference

1 reference

Chris J Malkin

1

1 reference

23 December 2017

Peter J Pugh

2

1 reference

23 December 2017

John N West

3

1 reference

23 December 2017

Edwin J R van Beek

4

1 reference

23 December 2017

T Hugh Jones

5

1 reference

23 December 2017

Kevin S Channer

6

1 reference

23 December 2017

publication date

10 August 2005

1 reference

23 December 2017

published in

European Heart Journal

1 reference

23 December 2017

volume

27

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

57-64

1 reference

23 December 2017

Epidemiology, aetiology, and prognosis of heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

The cardiovascular effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Hormonal profile in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Acute haemodynamic effects of testosterone in men with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Testosterone treatment for men with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Incremental shuttle walk test in the assessment of patients for heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Proof of the effect of testosterone on skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Left ventricular size and function in elite bodybuilders using anabolic steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Testosterone is a potent inhibitor of L-type Ca(2+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI443

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHI443

1 reference

23 December 2017

PubMed ID

16093267

1 reference

23 December 2017